Skip to content
Back to announcement

20231005_INAF_Laporan Informasi dan Fakta Material_31435316.pdf

Other Text extracted INAF

Source file signed link, expires in 15 minutes

This browser can't display the PDF inline. Open it in a new tab.

Extracted text 4

Page 1
Go To English Page

 Nomor Surat                           0979/CRS/X/2023

 Nama Perusahaan                       Indofarma Tbk.

 Kode Emiten                           INAF

 Lampiran                              3
                                       Laporan Informasi atau Fakta Material Penjelasan Terkait Permohonan
 Perihal
                                       Penundaan Kewajiban Pembayaran Utang terhadap PT Indofarma Tbk


Dengan ini kami untuk dan atas nama perusahaan menyampaikan Laporan Informasi atau Fakta Material sebagai
berikut:

 Nama Emiten atau Perusahaan Publik            Indofarma Tbk.

 Bidang Usaha                                  Industri Farmasi dan Kesehatan

 Telepon                                       (021) 8832 3971/75; 8590 8349/50

 Faksimili                                     (021) 8832 3972/73; 857 4503

 Alamat Surat Elektronik (email)               corsec@indofarma.id dan headoffice@indofarma.id


 Tanggal Kejadian                              27 September 2023
 Jenis Informasi atau Fakta Material           Penjelasan Terkait Permohonan Penundaan Kewajiban
                                               Pembayaran Utang terhadap PT Indofarma Tbk


 Uraian Informasi atau Fakta Material          Dengan hormat,

                                               Sehubungan dengan surat Otoritas Jasa Keuangan Nomor S-
                                               2494/PM.21/2023 tanggal 26 September 2023 Hal:
                                               Permintaan Penjelasan terkait Permohonan Penundaan
                                               Kewajiban Pembayaran Utang terhadap PT Indofarma Tbk,
                                               bersama ini kami sampaikan hal-hal terkait Penundaan
                                               Kewajiban Pembayaran Utang (PKPU) atas PT Indofarma Tbk
                                               (Perseroan) sebagaimana terlampir.
 Dampak kejadian, informasi atau fakta         -
 material tersebut terhadap kegiatan
 operasional, hukum, kondisi keuangan,
 atau kelangsungan usaha Emiten atau
 Perusahaan Publik



 Demikian untuk diketahui.


 Hormat Kami,
 Indofarma Tbk.




 Warjoko Sumedi

 Corporate Secretary




 Indofarma Tbk.
 Jl. Indofarma No. 1, Cikarang Barat, Bekasi, 17530
 Telepon : (021) 8832 3971/75; 8590 8349/50, Fax : (021) 8832 3972/73; 857 4503 ,
Page 2
Nama Pengirim                     Warjoko Sumedi

Jabatan                           Corporate Secretary
Tanggal dan Waktu                 05-10-2023 09:20

Lampiran                         1. S OJK 1439 - Penjelasan terkait PKPU.pdf


                                 2. Salinan Putusan Perkara PKPU pada PN JakPus.pdf


                                 3. Surat PN Jakarta Pusat PKPU 3415.pdf


  Dokumen ini merupakan dokumen resmi Indofarma Tbk. yang tidak memerlukan tanda tangan karena dihasilkan
 secara elektronik oleh sistem pelaporan elektronik. Indofarma Tbk. bertanggung jawab penuh atas informasi yang
                                           tertera didalam dokumen ini.
Page 3
Go To Indonesian Page

 Letter / Announcement No.            0979/CRS/X/2023

 Issuer Name                          Indofarma Tbk.

 Issuer Code                          INAF

 Attachment                           3

 Subject                              Material Information or Facts Report Explanation regarding the Request for
                                      Postponement of Debt Payment Obligations against PT Indofarma Tbk

The company hereby announce the Material Information or Facts Report as follows

 Name of Issuer or Public Company             Indofarma Tbk.

 Business Activities                          Industri Farmasi dan Kesehatan

 Telephone                                    (021) 8832 3971/75; 8590 8349/50

 Faximile                                     (021) 8832 3972/73; 857 4503

 Email Address                                corsec@indofarma.id dan headoffice@indofarma.id


 Date of Event                                27 September 2023

                                              Explanation regarding the Request for Postponement of Debt
 Type of Material Information or Facts        Payment Obligations against PT Indofarma Tbk

 Description of Material Information or       Yours faithfully,
 Facts
                                              In connection with the Financial Services Authority letter
                                              Number S-2494/PM.21/2023 dated September, 26 2023
                                              Subject: Request for Explanation regarding the Request for
                                              Postponement of Debt Payment Obligations against PT
                                              Indofarma Tbk, we hereby convey the matters related to
                                              Postponement of Debt Payment Obligations (PKPU) of PT
                                              Indofarma Tbk (Company) as attached.
 Impact of event, material information or     -
 facts towards Issuers or Public
 Company’s operational activities, legal,
 financial condition, or going concern




Thus to be informed accordingly.


Respectfully,
Indofarma Tbk.




Warjoko Sumedi

Corporate Secretary




Indofarma Tbk.
Jl. Indofarma No. 1, Cikarang Barat, Bekasi, 17530
Phone : (021) 8832 3971/75; 8590 8349/50, Fax : (021) 8832 3972/73; 857 4503 ,
Page 4
Sender Name                         Warjoko Sumedi

Function                            Corporate Secretary

Date and Time                       05-10-2023 09:20

Attachment                         1. S OJK 1439 - Penjelasan terkait PKPU.pdf


                                   2. Salinan Putusan Perkara PKPU pada PN JakPus.pdf


                                   3. Surat PN Jakarta Pusat PKPU 3415.pdf


  This is an official document of Indofarma Tbk. that does not require a signature as it was generated electronically
   by the electronic reporting system. Indofarma Tbk. is fully responsible for the information contained within this
                                                      document.

File

File Open PDF
Source IDX
Size0.01 MB
Published5 Oct 2023
Pages4
Characters6,135
Text sourceEmbedded text layer
OCR confidence—

Names mentioned 0 people and organisations named in the text · linked when the evidence is strong

The name pass has not read this document yet.

Extraction attempts how the parser did, and what it refused

Nothing structured was extracted from this document — the attempts below say why.

No extraction attempted yet.

↑↓ select ↵ open ⇧↵ see every result